ROS101,A Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Tixicity in Rat CIA Model of Rheumatic Arthritis

V. Previtali; N. Woodworth; M. H. Hopkins; J. H. Petersen; I. Ahnfelt-Ronne; M. H. Clausen

doi:10.1136/annrheumdis-2018-EWRR2019.126

ROS101,A Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Tixicity in Rat CIA Model of Rheumatic Arthritis

V. Previtali, N. Woodworth, M. H. Hopkins, J. H. Petersen, I. Ahnfelt-Ronne, M. H. Clausen

Department of Chemistry

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	P142
Journal	Annals of the Rheumatic Diseases
Volume	78
Issue number	Suppl. 1
Pages (from-to)	A62-A63
Number of pages	2
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2018-EWRR2019.126
Publication status	Published - 2019
Event	39th European Workshop for Rheumatology Research - Lyon, France Duration: 28 Feb 2019 → 2 Mar 2019 Conference number: 39

Workshop

Workshop	39th European Workshop for Rheumatology Research
Number	39
Country/Territory	France
City	Lyon
Period	28/02/2019 → 02/03/2019

Access to Document

10.1136/annrheumdis-2018-EWRR2019.126

OpenUrl availability

Full text

Cite this

Previtali, V., Woodworth, N., Hopkins, M. H., Petersen, J. H., Ahnfelt-Ronne, I., & Clausen, M. H. (2019). ROS101,A Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Tixicity in Rat CIA Model of Rheumatic Arthritis. Annals of the Rheumatic Diseases, 78(Suppl. 1), A62-A63. Article P142. https://doi.org/10.1136/annrheumdis-2018-EWRR2019.126

@article{fbb1b2a2e02f401b861bb2aeedd2e3a1,

title = "ROS101,A Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Tixicity in Rat CIA Model of Rheumatic Arthritis",

author = "V. Previtali and N. Woodworth and Hopkins, {M. H.} and Petersen, {J. H.} and I. Ahnfelt-Ronne and Clausen, {M. H.}",

year = "2019",

doi = "10.1136/annrheumdis-2018-EWRR2019.126",

language = "English",

volume = "78",

pages = "A62--A63",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 1",

note = "39th European Workshop for Rheumatology Research ; Conference date: 28-02-2019 Through 02-03-2019",

}

Previtali, V, Woodworth, N, Hopkins, MH, Petersen, JH, Ahnfelt-Ronne, I & Clausen, MH 2019, 'ROS101,A Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Tixicity in Rat CIA Model of Rheumatic Arthritis', Annals of the Rheumatic Diseases, vol. 78, no. Suppl. 1, P142, pp. A62-A63. https://doi.org/10.1136/annrheumdis-2018-EWRR2019.126

ROS101,A Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Tixicity in Rat CIA Model of Rheumatic Arthritis. / Previtali, V.; Woodworth, N.; Hopkins, M. H. et al.
In: Annals of the Rheumatic Diseases, Vol. 78, No. Suppl. 1, P142, 2019, p. A62-A63.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - ROS101,A Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Tixicity in Rat CIA Model of Rheumatic Arthritis

AU - Previtali, V.

AU - Woodworth, N.

AU - Hopkins, M. H.

AU - Petersen, J. H.

AU - Ahnfelt-Ronne, I.

AU - Clausen, M. H.

N1 - Conference code: 39

PY - 2019

Y1 - 2019

U2 - 10.1136/annrheumdis-2018-EWRR2019.126

DO - 10.1136/annrheumdis-2018-EWRR2019.126

M3 - Conference abstract in journal

SN - 0003-4967

VL - 78

SP - A62-A63

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 1

M1 - P142

T2 - 39th European Workshop for Rheumatology Research

Y2 - 28 February 2019 through 2 March 2019

ER -